Form D · Biotechnology

Autoimmunity Biologic Solutions Inc.

Houston, TX · CIK 0002045812

Offering snapshot reported May 6, 2026 · SEC filing

Reported sold
$3.21M
Offering amount: $3.21M
Investors reported
15
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Nov 8, 2024
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$1.6M$3.21MNov 22, 2024: $2,210,242.00Nov 22, 2024May 6, 2026: $3,209,233.00May 6, 2026

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$2,210,242 → $3,209,233
  • Reported investors12 → 15

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
May 6, 2026Amendment$3,209,233$998,991vs Nov 22, 202415SEC filing
Nov 22, 2024Initial$2,210,242No comparison12SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-530214
$130,256.37 of the total amount sold was from the conversion of securities and/or cancellation of indebtedness.

Source: Form D, filed May 6, 2026. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Gaddiel Galarza Munoz Executive
Mariano Garcia Blanco Director
Jimmy Lu Director
Brock Reeve Director
Eugene Williams Director, Executive

Issuer details

Industry: Biotechnology (See others in industry)

Address:
2710 Reed Rd, Suite 160
Houston, TX, 77051